Announce Date | 04/30/2025 |
EPS Normalized Actual | $1.3 (Beat by $0.01) |
EPS GAAP Actual | $1.3 (Beat by $0.01) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 9.73 | 15.12 | 9.38551 | 10.31935 | 1 |
Dec 2028 | 10.75 | 13.69 | 10.11173 | 11.29341 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | 0 | 0B | -INF% | 0M |
FQ4 2024 (Dec 2024) | 1.5 | 1.5 | 2.362B | 13.8% | 2362M |
FQ3 2024 (Sep 2024) | 0 | 0 | 2.223B | 23.17% | 2223M |
FQ2 2024 (Jun 2024) | 1.3 | 1.3 | 1.763B | 4.31% | 1763M |
FQ1 2024 (Mar 2024) | 1.1 | 1.1 | 1.598B | -2.94% | 1598M |
FQ4 2023 (Dec 2023) | 1.65 | 1.65 | 2.036B | 0.83% | 2036M |
FQ3 2023 (Sep 2023) | 1.48 | 1.48 | 1.708B | 3.98% | 1708M |
FQ2 2023 (Jun 2023) | 1.49 | 1.49 | 1.687B | 3.02% | 1687M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.21 | -- | 2.18229 | 2.24428 | 4 |
FQ3 2027 (Sep 2027) | 1.88 | -- | 1.85643 | 1.90916 | 7 |
FQ2 2027 (Jun 2027) | 1.79 | -- | 1.76755 | 1.81777 | 4 |
FQ1 2027 (Mar 2027) | 1.6 | -- | 1.57994 | 1.62482 | 4 |
FQ4 2026 (Oct 2026) | 1.8667 | -- | 1.73538 | 1.94207 | 9 |
FQ3 2026 (Jul 2026) | 1.70115 | -- | 1.58148 | 1.76983 | 9 |
FQ2 2026 (Jun 2026) | 1.78341 | -- | 1.69945 | 1.86746 | 9 |
FQ1 2026 (Mar 2026) | 1.59783 | -- | 1.52261 | 1.67313 | 9 |
FQ4 2025 (Oct 2025) | 1.67372 | 10.38 | 1.55598 | 1.7413 | 7 |
FQ3 2025 (Jul 2025) | 1.53208 | -- | 1.4243 | 1.59394 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.22B | -- | 2.2B | 2.25B | 9 |
FQ3 2027 (Sep 2027) | 2.19B | -- | 2.17B | 2.21B | 9 |
FQ2 2027 (Jun 2027) | 2.15B | -- | 2.13B | 2.18B | 9 |
FQ1 2027 (Mar 2027) | 2.12B | -- | 2.1B | 2.15B | 9 |
FQ4 2026 (Oct 2026) | 2.19B | -- | 2.07B | 2.25B | 6 |
FQ3 2026 (Jul 2026) | 2.1B | -- | 1.98B | 2.16B | 6 |
FQ2 2026 (Jun 2026) | 2.13B | -- | 2.05B | 2.21B | 12 |
FQ1 2026 (Mar 2026) | 2.01B | -- | 1.93B | 2.08B | 7 |
FQ4 2025 (Oct 2025) | 2.04B | -15.81 | 1.93B | 2.1B | 10 |
FQ3 2025 (Jul 2025) | 1.96B | -13.47 | 1.85B | 2.02B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
FQ4 2024 (Dec 2024) | 1.5 | 1.5 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 1.3 | 1.3 | 100% | |
FQ1 2024 (Mar 2024) | 1.1 | 1.1 | 100% | |
FQ4 2023 (Dec 2023) | 1.65 | 1.65 | 100% | |
FQ3 2023 (Sep 2023) | 1.48 | 1.48 | 100% | |
FQ2 2023 (Jun 2023) | 1.49 | 1.49 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
FQ4 2024 (Dec 2024) | $0B | $2.36B | $2362M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.22B | $2223M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.76B | $1763M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.6B | $1598M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.04B | $2036M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.71B | $1708M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.69B | $1687M | 100% |